FTSE 100 Climbs Amid Mixed Corporate Updates And Global Trade Speculations
The FTSE 100 concluded the day with a 0.6% increase, driven by healthcare gains and AstraZeneca's strong profit report. Despite efforts hindered in other sectors like chemicals, investor attention is focused on upcoming Federal Reserve decisions and ongoing global trade discussions involving the US, China, and the European Union.
The FTSE 100 closed upward at 0.6% on Tuesday, bolstered by strong performances in healthcare, specifically AstraZeneca's standout quarterly results. This optimism comes as investors brace for the Federal Reserve's crucial policy decisions expected on Wednesday.
Healthcare stocks notably surged by 2.2%, following AstraZeneca's profit triumph, which saw its shares elevate by 3.4%. Banking shares climbed in tandem with European counterparts while precious metal miners enjoyed gains amid stable gold prices.
Conversely, chemical stocks suffered, with Croda International's disappointing sales report leading to significant losses. This session left the FTSE 250 down 0.7%, impacted by negative reports from Inchcape and Greggs. Concurrently, global trade discussions continue, with US-European tariffs remaining a focal point.
(With inputs from agencies.)
ALSO READ
U.S. Consumer Prices Rise Amid Tariff Pressures: Inflation Outlook and Federal Reserve Response
Trump Faces Off with Powell: Speculations on Federal Reserve Leadership
Trump's Tug-of-War with the Federal Reserve
Trump Considers Scott Bessent for Federal Reserve Leadership
Potential Shakeup at the Federal Reserve: Trump's Candidates for Chairman
Google News